In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

Chronic heart failure and diabetes: two frequent companions in clinical practice

Session Poster session 1 Saturday 08:30 -17:30

Speaker Associate Professor Camelia Cristina Diaconu

Congress : Heart Failure 2015

  • Topic : heart failure
  • Sub-topic : Chronic Heart Failure
  • Session type : Poster Session
  • FP Number : P233

Authors : C C Diaconu (Bucharest,RO), LA Balaceanu (Bucharest,RO), M Ilie (Bucharest,RO), M Hostiuc (Bucharest,RO), D Bartos (Bucharest,RO)

15 views

Authors:
C C Diaconu1 , LA Balaceanu2 , M Ilie1 , M Hostiuc1 , D Bartos1 , 1University of Medicine and Pharmacy Carol Davila, Emergency Clinical Hospital Floreasca - Bucharest - Romania , 2University of Medicine and Pharmacy Carol Davila, Emergency Clinical Hospital Sf. Ioan - Bucharest - Romania ,

Citation:
European Journal of Heart Failure Abstracts Supplement ( 2015 ) 17 ( Supplement 1 ), 47

Purpose: Diabetes, a frequent comorbidity in patients with heart failure, influences the clinical characteristics in patients hospitalized for chronic heart failure. The objective of the study was to analyze the clinical characteristics of patients with chronic heart failure and diabetes, hospitalized in the internal medicine clinic of a university emergency hospital over a period of 6 months, as compared with those without diabetes.

Methods: A total of 412 patients with chronic heart failure were included. Clinical and laboratory variables, along with the treatment, were retrospectively reviewed from the hospital database.

Results: From the 412 patients hospitalized with chronic heart failure, 67 were diabetics (16.26%). The main comorbidities in the group of patients with heart failure and diabetes were: 48 patients had arterial hypertension (71.64%), 43 dyslipidemia (64.17%), 38 ischemic heart disease (56.71%), 33 valvular diseases (49.25%), 21 chronic kidney disease (31.34%), 20 atrial fibrillation (29.85%), 18 dilatative cardiomyopathy (26.86%), 13 pulmonary hypertension (19.40%). Heart failure patients with diabetes were younger (mean age 65 ± 2 y vs 71 ± 3 y) and had a higher prevalence of ischemic etiology and atrial fibrillation comparing with heart failure patients without diabetes. Also, in-hospital mortality and length of stay (8.2 vs 6.7 days) were higher in diabetics. Sex distribution of patients with heart failure and diabetes was: 31 women (46.26%) and 36 men (53.73%). 86.56% of heart failure patients with diabetes were obese; only 32.75% of those without diabetes were obese. All diabetic patients were treated with oral antidiabetics; 14 were treated with insulin.

Conclusions: Heart failure patients with diabetes had higher short-term mortality and duration of hospitalization compared with patients without diabetes; also, they were younger than non-diabetic patients. Diabetic patients with heart failure had greater body mass index than heart failure patients without diabetes and were more likely to have more advanced renal disease.



Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are